We are live on ! Find out more
NRXP icon

NRX Pharmaceuticals
NRXP

15 hedge funds and large institutions have $23.1M invested in NRX Pharmaceuticals in 2017 Q4 according to their latest regulatory filings, with 15 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

9.37% more ownership

Funds ownership: 0% → 9.37% (+9.4%)

Holders
15
Holders Change
+15
Holders Change %
–
% of All Funds
0.34%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
15
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
PAMP
Polar Asset Management Partners
Ontario, Canada
+$4.17M
2
HIM
HGC Investment Management
Ontario, Canada
+$3.92M
3
OAM
Oxford Asset Management
United Kingdom
+$2.03M
4
AA
AQR Arbitrage
Connecticut
+$1.93M
5
GCL
Glazer Capital LLC
New York
+$1.86M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
PAMP
1
Polar Asset Management Partners
Ontario, Canada
$4.18M +$4.17M +43,080 New
HIM
2
HGC Investment Management
Ontario, Canada
$3.93M +$3.92M +40,492 New
OAM
3
Oxford Asset Management
United Kingdom
$2.03M +$2.03M +21,000 New
AA
4
AQR Arbitrage
Connecticut
$1.94M +$1.93M +20,000 New
GCL
5
Glazer Capital LLC
New York
$1.86M +$1.86M +19,189 New
WAM
6
Weiss Asset Management
Massachusetts
$1.7M +$1.7M +17,580 New
WRBC
7
W.R. Berkley Corp
Connecticut
$1.68M +$1.63M +16,824 New
YCM
8
Yakira Capital Management
Connecticut
$1.6M +$1.6M +16,500 New
KIM
9
Karpus Investment Management
New York
$884K +$881K +9,110 New
BCM
10
Bluefin Capital Management
New York
$776K +$774K +8,000 New
DAM
11
Deltec Asset Management
New York
$728K +$725K +7,500 New
KPF
12
K2 Principal Fund
Ontario, Canada
$728K +$727K +7,518 New
PC
13
Periscope Capital
Ontario, Canada
$490K +$487K +5,040 New
BCM
14
Basso Capital Management
Connecticut
$484K +$484K +5,000 New
VF
15
Virtu Financial
New York
$120K +$120K +1,241 New

NRXP Hedge Fund Activity: Q4 2017 in Review

15 of the 4,410 institutional investors tracked by Wall St. Rank reported a position in NRX Pharmaceuticals (NRXP) for Q4 2017, worth a combined $23.1M.

Buyers outnumbered sellers: 15 funds opened new NRXP positions and 0 closed out — a net gain of 15 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Polar Asset Management Partners, opening a new position worth an estimated $4.17M.

  • 15 institutional investors held NRX Pharmaceuticals (NRXP) as of Q4 2017, up from 0 in Q3 2017.
  • Funds reported $23.1M of NRX Pharmaceuticals stock for Q4 2017.
  • 15 funds opened new NRX Pharmaceuticals positions in Q4 2017 and 0 closed out, a net change of +15 holders.
  • The largest NRX Pharmaceuticals buyer in Q4 2017 was Polar Asset Management Partners, an estimated $4.17M added.

Based on aggregated 13F filings for Q4 2017.